**Executive Summary**
This document is a response to Unstarred Question No. 964 in the Lok Sabha, answered on December 5, 2025, regarding the government's efforts to promote the medical device industry. It outlines various initiatives and financial assistance schemes for setting up medical device industries, detailing their progress and impact. Key dates include the scheme launch date of the Strengthening Medical Device Industry scheme on November 8, 2024 and the performance-linked incentive period for the PLI scheme from FY2022-23 to FY2026-27.
**Key Points / Main Content**
* **Government Efforts to Promote the Medical Device Industry:**
* The Government has made wide-ranging efforts to promote the medical device industry through provision of financial assistance for setting up of medical device industry.
* State-wise details of medical device manufacturing sites licensed in the country, including Maharashtra, are provided.
* **Production Linked Incentive (PLI) Scheme:**
* Budgetary outlay of ₹3,420 crore with a five-year performance-linked incentive period from FY2022-23 to FY2026-27.
* Financial incentives for incremental sales of domestically manufactured medical devices in specific segments.
* As of September 2025, 22 greenfield projects commissioned, with production started for 55 products.
* Cumulative eligible sales of ₹12,344.37 crore have been made, including export sales worth ₹5,869.36 crore.
* **Scheme for Promotion of Medical Devices Parks:**
* Aims to provide easy access to world-class infrastructure facilities.
* Three parks approved in Greater Noida (Uttar Pradesh), Ujjain (Madhya Pradesh), and Kanchipuram (Tamil Nadu).
* Total project cost of ₹871.11 crore, with ₹100 crore Central assistance for each park.
* As of November 2025, ₹180 crore released; civil construction is at the final stages.
* As of September 2025, 194 manufacturers have been allotted land, and 34 units have commenced construction.
* **Scheme for Strengthening Medical Device Industry:**
* Launched on November 8, 2024, with a financial outlay of ₹500 crore.
* Aims to strengthen the industry by supporting manufacturing, skill development, clinical studies, infrastructure, and industry promotion.
* Includes sub-schemes like Common Facilities, Marginal Investment, Capacity Building, Clinical Studies Support, and Device Promotion.
* **Licensed Manufacturing Sites (2021-2025):**
* The document includes a detailed state-wise breakdown of the number of medical device manufacturing sites licensed during the period from 2021 to 2025.
* Gujarat leads with 738 licensed sites, followed by Maharashtra with 721 and Delhi with 291.
**Impact Analysis**
**Medical Device Manufacturers**
* **Impact:** Beneficiaries of financial incentives and infrastructure support, increased competitiveness, reduced production costs, opportunities for growth and expansion.
* **Action Required:** Apply for and comply with the requirements of the PLI Scheme, and make use of the infrastructure and support offered by the Medical Devices Parks and the Strengthening Medical Device Industry scheme.
**States (Uttar Pradesh, Madhya Pradesh, Tamil Nadu)**
* **Impact:** Economic development through establishment of Medical Device Parks, job creation, enhanced industrial competitiveness.
* **Action Required:** Facilitate the establishment and operation of Medical Device Parks, ensure the provision of necessary infrastructure and support to attract investors and manufacturers.
**Medical Device Industry Stakeholders (Component Suppliers, Skill Development Providers, Clinical Research Organizations)**
* **Impact:** Opportunities to participate in the value chain, increased demand for services, potential for growth and innovation.
* **Action Required:** Align with the goals of the Strengthening Medical Device Industry scheme, explore opportunities for collaboration and participation in the supported activities.
Key Entities Referenced
Production Linked Incentive (PLI) scheme for promoting domestic manufacturing of Medical Devices: A scheme with a budgetary outlay to provide financial incentives for the domestic manufacturing of medical devices.
Scheme for Strengthening Medical Device Industry: A scheme aimed at strengthening the medical device industry by providing support in critical areas.
Scheme for Promotion of Medical Devices Parks: A scheme designed to provide access to world-class infrastructure facilities for medical device units in medical device parks.
Ministry of Chemicals and Fertilizers: The Indian government ministry responsible for the Department of Pharmaceuticals, which is involved in promoting the medical device industry.
Maharashtra: A state in India, specifically mentioned for its medical device manufacturing sector and as a focus area for data collection in the Lok Sabha question.
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
DEPARTMENT OF PHARMACEUTICALS
LOK SABHA
UNSTARRED QUESTION No. 964
TO BE ANSWERED ON 5TH DECEMBER, 2025
Medical Devices Industries
†964. Shri Bhumare Sandipanrao Asaram:
Smt. Delkar Kalaben Mohanbhai:
Shri Gyaneshwar Patil:
Shri Nilesh Dnyandev Lanke:
Dr. Shivaji Bandappa Kalge:
Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:
(a) the efforts being made by the Government to promote the medical device industry in the
country;
(b) the number of new medical device industries set up in the country, State-wise particularly
in the State of Maharashtra during the last five years;
(c) whether the Government is providing any financial assistance for setting up these industries,
if so, the details thereof; and
(d) whether new medical devices industries have been set up in the State of Maharashtra during
the last five years and if so, the details thereof?
ANSWER
THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND
FERTILIZERS
(SMT. ANUPRIYA PATEL)
(a) to (d): The number and State-wise details of medical device manufacturing sites licensed in
the country, including in the State of Maharashtra, during the last five years, are given in the
Annex.
The Government has made wide-ranging efforts to promote the medical device industry
in the country, including through provision of financial assistance for the setting up of medical
device industry. These efforts include the following:
(i) Production Linked Incentive (PLI) scheme for promoting domestic manufacturing
of Medical Devices: This scheme has a budgetary outlay of ₹3,420 crore and a five-
year performance-linked incentive period from FY2022-23 to FY2026-27. Under
the scheme, selected companies are eligible for financial incentive for incremental
sales of domestically manufactured medical devices in the radiotherapy, imaging
device, anaesthesia, cardio-respiratory and critical care and implant device
segments, for a period of five years. As of September 2025, 22 greenfield projects
have been commissioned and production has started for 55 products, which include
high-end medical devices on which the country has been highly import-dependent,
such as linear accelerators, machines for MRI and CT scans and mammograms, C-arm X-ray machines, MRI coils and ultrasound machines. Till September 2025,
cumulative eligible sales of ₹12,344.37 crore have been made under the scheme,
including export sales worth ₹5,869.36 crore.
(ii) Scheme for Promotion of Medical Devices Parks: The scheme aims to provide easy
access to world-class, common infrastructure facilities to medical device units set
up in medical device parks. Under this scheme, three parks have been approved
and are at an advanced stage of development in Greater Noida (Uttar Pradesh),
Ujjain (Madhya Pradesh) and Kanchipuram (Tamil Nadu) districts. The total
project cost of these is ₹871.11 crore, with Central assistance to the tune of ₹100
crore each for creation of common infrastructure facilities, which is expected to
enhance industry’s competitiveness and reduce production costs through
optimisation of resources and economies of scale. As of November 2025, out of a
total of ₹300 crore for the three parks, a total of ₹180 crore stood released. Civil
construction for the three parks is at the final stages. As of September 2025, 194
medical devices manufacturers have been allotted land in the three parks in a
298.58 acre area and 34 units have commenced construction of their plants.
(iii) Scheme for Strengthening Medical Device Industry: This scheme has been
launched on 8.11.2024 with a financial outlay of ₹500 crore. It aims to strengthen
the medical device industry by providing support in critical areas, including
manufacturing of key components and accessories, skill development, support for
clinical studies, development of common infrastructure, and industry promotion
and consists of the following sub-schemes:
(1) Common Facilities for Medical Devices Clusters;
(2) Marginal Investment Scheme for Reducing Import Dependence;
(3) Capacity Building and Skill Development for Medical Devices;
(4) Medical Device Clinical Studies Support Scheme; and
(5) Medical Device Promotion Scheme.Annexure
Annexure referred to in the reply to parts (a) and (d) of the LOK SABHA UNSTARRED
Q. NO. 964 for answer on 5.12.2025, regarding Medical Devices Industries
Number and State-wise details of medical device manufacturing sites licensed in the
country, including in the State of Maharashtra, during the last five years
Number of manufacturing site licensed
State / Union territory
during the period from 2021 to 2025
Andhra Pradesh 58
Assam 7
Bihar 39
Chhattisgarh 13
Dadra and Nagar Haveli and Daman and Diu 34
Delhi 291
Goa 18
Gujarat 738
Haryana 302
Himachal Pradesh 49
Jammu And Kashmir 12
Jharkhand 3
Karnataka 262
Kerala 187
Madhya Pradesh 78
Maharashtra 721
Manipur 3
Orissa 38
Puducherry 18
Punjab 78
Rajasthan 118
Tamil Nadu 346
Telangana 194
Uttarakhand 60
Uttar Pradesh 346
West Bengal 62
*****